Savara Inc SVRA

$4.81 -0.24 (-4.66%)

Valuation

Market cap
1,036,546,000
Revenue TTM
$0
Net income TTM
$-118,840,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.21

Trading

Volume
2,653,300
Avg volume
1,786,312
Day's range
$4.76 – $5.16
Shares out
205,460,000
Stochastic %K
6%
Beta
0.20
Analysts
Strong Sell
Price target
$10.94

Price

Company profile

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.

Industry
Biotechnology
Sector
Healthcare
Phone
(512) 614-1848
Website
https://www.savarapharma.com
Address
The Tannery Building, Suite 200 19 West College Avenue, Yardley, United States

Latest news

No headlines yet.

Stocktwits

Flydown Oct 3, 7:07 AM
$SVRA Shorters in action but I hope in strong crash in yuor face!
0 replies
JambaPotato Oct 2, 9:05 PM
$SVRA Lot's of odd lot selling today
1 replies
Vwill33 Oct 2, 8:19 PM
$SVRA wtf is going on
1 replies
Richterscale Sep 30, 8:00 PM
$SVRA They re seriously f ing with the share price
2 replies
NT72 Sep 30, 7:47 PM
$SVRA Significant volume out of nowhere
2 replies
Richterscale Sep 30, 7:46 PM
$SVRA 5 MILLION in volume!!
0 replies
Richterscale Sep 30, 7:01 PM
$SVRA Q2 hedges loaded up super heavy. Q3 silence … I’ll gladly take $17$-20 for my shares. However if it fails it could easily head bad to $1 IMO. I owned this at $11 then a failure. Bain came in and it went from $.90 to $1.50 then $3.50 before settling. This PDUFA has been long awaited…The suspense is driving me nuts!
3 replies
Flydown Sep 30, 5:19 AM
$SVRA Watch out for short covering!!!
0 replies